Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Aripiprazole Once-Monthly is a Cost-Effective Therapeutic Option in the Maintenance Treatment of Schizophrenia: Results from a Markov Model
C Sapin, M J Tempest, F Gaughran, et al.
Schizophrenia Research
|
March 28, 1998
Increased soluble interleukin 2 receptor levels in schizophrenia
F Gaughran, E O'Neill, M Cole, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
July 3, 2007
Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy
L M Davies, S Lewis, P B Jones, et al.
Journal of Psychiatric and Mental Health Nursing
|
May 17, 2013
Provision of health promotion programmes to people with serious mental illness: a mapping exercise of four South London boroughs
C O'Brien, P Gardner-Sood, S K Corlett, et al.
BMC Psychiatry
|
March 23, 2016
Clinical correlates of vitamin D deficiency in established psychosis
J Lally, P Gardner-Sood, M Firdosi, et al.
Acta Psychiatrica Scandinavica
|
September 10, 2014
The practical management of refractory schizophrenia--the Maudsley Treatment REview and Assessment Team service approach
K Beck, R McCutcheon, M A P Bloomfield, et al.
Social Psychiatry and Psychiatric Epidemiology
|
February 6, 2016
Ethnicity and cardiovascular health inequalities in people with severe mental illnesses: protocol for the E-CHASM study
J Das-Munshi, M Ashworth, F Gaughran, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 16, 2016
Type 2 diabetes mellitus in people with severe mental illness: inequalities by ethnicity and age. Cross-sectional analysis of 588 408 records from the UK
J Das-Munshi, M Ashworth, M E Dewey, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
December 27, 2014
Reasons for cannabis use in first-episode psychosis: does strength of endorsement change over 12 months?
A Kolliakou, D Castle, H Sallis, et al.
Psychological Medicine
|
September 19, 2015
Impact of childhood adversities on specific symptom dimensions in first-episode psychosis
O Ajnakina, A Trotta, E Oakley-Hannibal, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Aripiprazole Once-Monthly is a Cost-Effective Therapeutic Option in the Maintenance Treatment of Schizophrenia: Results from a Markov Model
C Sapin, M J Tempest, F Gaughran, et al.
Schizophrenia Research
|
March 28, 1998
Increased soluble interleukin 2 receptor levels in schizophrenia
F Gaughran, E O'Neill, M Cole, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
July 3, 2007
Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy
L M Davies, S Lewis, P B Jones, et al.
Journal of Psychiatric and Mental Health Nursing
|
May 17, 2013
Provision of health promotion programmes to people with serious mental illness: a mapping exercise of four South London boroughs
C O'Brien, P Gardner-Sood, S K Corlett, et al.
BMC Psychiatry
|
March 23, 2016
Clinical correlates of vitamin D deficiency in established psychosis
J Lally, P Gardner-Sood, M Firdosi, et al.
Acta Psychiatrica Scandinavica
|
September 10, 2014
The practical management of refractory schizophrenia--the Maudsley Treatment REview and Assessment Team service approach
K Beck, R McCutcheon, M A P Bloomfield, et al.
Social Psychiatry and Psychiatric Epidemiology
|
February 6, 2016
Ethnicity and cardiovascular health inequalities in people with severe mental illnesses: protocol for the E-CHASM study
J Das-Munshi, M Ashworth, F Gaughran, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 16, 2016
Type 2 diabetes mellitus in people with severe mental illness: inequalities by ethnicity and age. Cross-sectional analysis of 588 408 records from the UK
J Das-Munshi, M Ashworth, M E Dewey, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
December 27, 2014
Reasons for cannabis use in first-episode psychosis: does strength of endorsement change over 12 months?
A Kolliakou, D Castle, H Sallis, et al.
Psychological Medicine
|
September 19, 2015
Impact of childhood adversities on specific symptom dimensions in first-episode psychosis
O Ajnakina, A Trotta, E Oakley-Hannibal, et al.
Page
of 3